Reg4, a member of the Reg multigene family, is highly upregulated in many gastrointestinal cancers including gastric cancer (GC). The enhanced expression of Reg4 is associated with the resistance of GC to 5-fluorouracil (5-FU), while the underlying mechanism is not clear. The aim of the present study was to explore the resistant mechanism underlying 5-FU resistance.
Background
Gastric cancer (GC) is the third leading cause of cancer-related mortality in China [1] . While early stage gastric cancer has a favorable prognosis [2] ; most GC patients are diagnosed at advanced stages when effective therapeutics are not readily available [3] . As a result, the 5-year survival rate of late stage GC is less than 20%-25% and the median survival time is only 6-15 months [4, 5] .
The 5-fluorouracil (5-FU) based chemotherapy is a standard treatment for patients with advanced GC [6] . Although combining 5-FU with cisplatin, docetaxel, or oxaliplatin can improve treatment response [7] , resistance to 5-FU in GC is still an intractable issue in the clinic. It was reported that upregulation of the enzymes associated with 5-FU metabolism such as thymidylate synthase (TS), orotate phosphoribosyl transferase (OPRT) and dihydropyrimidine dehydrogenase (DPD) were involved in the 5-FU-resistance [8] . Besides, alterations of apoptosis pathway [9] or proteins in response to DNA damage [10, 11] can lead to resistance to 5-FU.
Our previous study [12] indicated that the mRNA levels of regenerating family member 4 (Reg4) were strongly related to the intrinsic resistance of GC cells to 5-FU. As a member of the REG gene family, Reg4 was originally identified by highthrough put sequencing analysis of an inflammatory bowel disease library [13] , and its overexpression was proven to be closely correlated to the carcinogenesis in some types of cancer [14] [15] [16] [17] [18] [19] . In the present study, the role of Reg4 in promoting 5-FU-resistance in GC cells was confirmed and its mechanism was investigated.
Material and Methods

Cell lines and culture
Human gastric carcinoma cell lines SGC7901, AGS, MKN28, MKN45, and BGC823 were bought from the Cell Bank of the Chinese Academy of Sciences, Shanghai, China. AGS cells were maintained in F12 medium (Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco); other cells were maintained in RPMI 1640 medium (Gibco) supplemented with 10% FBS. All cells were cultured in a 5% CO 2 and 37°C incubator.
Western blot
Cells were harvested and lysed in NP40 buffer with protease inhibitor cocktails added. The concentration of total protein was measured using the Bradford calorimetric assay (Bio-Rad Laboratories, CA, USA). 
(DPD reverse). Cycling conditions were 95°C for 10 minute, 40 repeats of 95 °C for 15 seconds followed by 60°C for one minute. The expression levels of mRNAs were calculated using the 2 -DDCt method which was described before [20] .
Reg4 knockdown and overexpression
Specific siRNAs targeting human Reg4 (siReg4-1 and siReg4-2) and non-targeting control siRNA (siCtrl) were designed and provided by Shanghai GenePharma Co., Ltd, China. The siReg4-1 sequences were 5'-AAGUGGCUAUCAGAGAAGCTT-3' and 5'-GCUUCUCUGAUAGCCACUUTT-3'. The siReg4-2 sequences were 5'-GACAGAAGGAAGAAACUCATT-3' and 5'-UGAGUU UCUUCCUUCUGUCTT-3'. The siCtrl sequences were 5'-UUCU CCGAACGUGUCACGUTT-3' and 5'-ACGUGACACGUUCGGAG AATT-3'. amplified using polymerase chain reaction (PCR) and subcloned into the p3 × FLAG-CMV-10 vector (Sigma, St. Louis, MO, USA). The p3 × FLAG vector was used as control. All transfections were performed using Lipofectamine3000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. After transfection for 24 hours, the alterations of Reg4 expression were evaluated by Western blot and RT-qPCR.
Treatment of 5-FU and cell viability assay
The 5-FU was purchased from Sigma Chemical Co. (St. Louis, MO, USA). Stock solutions of 5-FU were prepared in sterile DMSO and stored at 4°C prior to use.
Twenty-four hours post transfection, cells were seeded at a density of 3,000 cells per well in 96-well plates. The next day, different concentrations of 5-FU were added into the plates and after 48 hours, cell viability was determined using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT, Sigma) assay.
Two proper concentrations of 5-FU for each cell line were chosen from the results of cell viability assay. Transfected cells were treated with 5-FU in these two concentrations and then harvested for flow cytometry measurement, Western bolt and RT-qPCR analyses.
Flow cytometry analysis of apoptosis cells
Those 5-FU treated transfected cells were harvested by Accutase-Enyme Cell Detachment Medium (eBiosciences, San Diego, CA, USA) and stained with the PE Annexin V Apoptosis Detection kit (BD Biosicences, San Diego, CA, USA) according to the manufacturer's instructions. Measurements were performed on a FACS Calibur flow cytometer and results were analyzed by CellQuest software (BD Biosicences, San Diego, CA, USA).
Statistical analysis SPSS 21.0 (IBM) was used for data analysis. Data from a minimum of three independent experiments were expressed as means ± standard deviations (SD). Comparisons between groups were carried out using the one-way ANOVA with Bonferroni post hoc test or Student's t-test, and a p value of <0.05 was considered statistically significant.
Results
Reg4 knockdown and overexpression
First, we evaluated the expression of Reg4 in five GC cell lines. As shown in Figure 1A , the protein expression of Reg4 was high in AGS, MKN28, and MKN45, but low in BGC-823, and null in SGC7901. Hence AGS and SGC7901 cells were selected to do knockdown and overexpression of Reg4, respectively. As illustrated in Figure 1B -1E, both on protein and mRNA levels, AGS-siReg4-1 and AGS-siReg4-2 expressed less Reg4 than AGS-siCtrl, and SGC-Flag-Reg4 cells expressed more Reg4 than SGC-Flag cells.
Reg4 mediated 5-FU resistance of GC cells
The cell viability assay showed that after 5-FU treatment, AGSsiCtrl cells had better viability than AGS-siReg4-1 and AGSsiReg4-2 cells (Figure 2A ) and similarly, SGC-Flag-Reg4 cells had higher cell viability than SGC-Flag cells ( Figure 2B ). The concentrations of 5-FU for next assays were set as 3 ug/mL and 30 ug/mL for AGS, 0.5 ug/mL and 5 ug/mL for SGC7901.
Expression of the enzymes associated with 5-FU metabolism
Results from RT-qPCR indicated that there was no obvious difference in expression of enzymes associated with 5-FU metabolism (TS, OPRT, and DPD) between control cells and AGS knockdown or overexpression cells (Figure 3 ).
Reg4 inhibited apoptosis of GC cells
As displayed in Figure 4 , after treated with 5-FU, in both of the two concentrations, AGS-siReg4-1 and AGS siReg4-2 cells had significantly higher percentages of apoptosis cells than AGSsiCtrl cells, and SGC-Flag-Reg4 cells had lower apoptosis cells content than SGC-Flag-Ctrl cells.
Reg4 regulated the MAPK/Erk/Bim signaling pathway
The Western blot showed that compared with AGS-siCtrl cells, AGS-siReg4-1 and AGS-siReg4-2 cells expressed less phosphorylated Erk1/2 (p-Erk1/2), more apoptosis proteins including Bim, Bax, as well as active-caspase3, and comparable total-Erk1/2 (T-Erk1/2) and Bcl-2 ( Figure 5 ). Consistent trend was detected in SGC-Flag-Reg4 and SGC-Flag cells ( Figure 5 ).
Discussion
The present study showed that Reg4 increased the 5-FUtolerability of GC cells in vitro, which was consistent with some previous findings that GC patients with high-expression Reg4 had poor response to 5-FU treatment in comparison to those with low-expression of Reg4 [21] .
As has been reported in pancreatic cancer studies, that Reg4 has anti-apoptotic properties when exposed to chemotherapy [22] , 
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our results from flow cytometry assay indicated Reg4 decreased 5-FU inducing apoptosis in GC cells. Moreover, our study found that the MAPK/Erk pathway was activated when Reg4 exerted anti-apoptotic effects. It is well acknowledged that the MAPK/Erk pathway plays a crucial role in multiple cellular processes such as cell proliferation, differentiation, adhesion, and migration [23] . Furthermore, it has been reported that Reg4 could modulate receptor tyrosine kinases (RTKs) in prostate cancer and colon cancer [24] . With the addition of acknowledgement that the MAPK pathway is one of the signaling transduction downstream of many RTKs [25] , we may suppose that Reg4 may activate the MAPK pathway through influencing RTKs. The mechanism needs to be further explored.
As for apoptotic cascade, MAPK/Erk signaling could repress pro-apoptotic proteins such as Bad and Bim to achieve cell survival [26, 27] . In this study, Bim was found to be reduced when Reg4 was overexpressed. Bim, a BH3-domain-only molecule belonging to the Bcl-2 family, is responsible for mitochondrial stress-induced apoptosis [28, 29] . As suggested before, Bim can directly bind to and activate Bax; its binding to pro-survival Bcl-2 homologs can indirectly promote the activation of Bax [29] . Thereupon the primed Bax enables the caspase pathway which ultimately leads to cell death [28] . Our results from Western blot analysis ( Figure 5 ) were consistent with the aforementioned understanding, and therefore, we speculated that Reg4 enhanced 5-FU-resistance through affecting the MAPK/Erk/Bim pathway.
However, the present study did not find any alteration of enzymes involved in 5-FU metabolism (DPD, TS, and OPRT) which are known to be important in the formation of 5-FUresistance [21] . In addition, several studies concentrating on colorectal cancer found that Reg4 could inhibit the expression of Bcl-2 [30, 31] while in this study there was no difference in Bcl-2 expression among cells with diverse levels of Reg4. We considered that these disparities were partly caused by the different cell lines used in experiments.
